Industry News
Phosphagenics names new CEO
Phosphagenics (ASX:POH) has appointed Dr Ross Murdoch as its new CEO and has received ethics approval for a pilot trial of TPM/Oxycodone in post-herpetic neuralgia.
[ + ]Monash, Janssen-Cilag tackle autoimmune diseases
Monash University has entered a collaborative research partnership with Janssen-Cilag to explore potential new treatments for autoimmune diseases including rheumatoid arthritis.
[ + ]Regulatory registration of Qiagen lung cancer companion diagnostic
Qiagen has announced the CE-IVD marking of its liquid biopsy-based companion diagnostic that analyses circulating nucleic acids obtained from blood samples to assess a genomic mutation in patients with non-small cell lung cancer (NSCLC). [ + ]
Call for papers - Laboratory Management and Design Conferences
The 2015 Laboratory Management and Design Conferences will be held from 16-19 November at Etihad Stadium, Melbourne. Science Industry Australia is now calling for papers and presentations for the two conferences. [ + ]
Join us in our New Year's resolutions to grow the biotech industry
The time is here to list AusBiotech's New Year's resolutions, which will buoy and grow the Australian biotechnology industry, support your success and ensure 2015 is the best year yet.
[ + ]Dako and Cell Signaling Technology partner in companion diagnostics
Antibody provider Cell Signaling Technology (CST) has entered into a strategic partnership to supply antibodies for use in Dako companion diagnostics products. [ + ]
LBT set to lose bioMérieux licence deal
LBT Innovations (ASX:LBT) is set to lose a substantial source of income, with licensee bioMérieux planning to terminate its agreement with the Australian lab technology provider.
[ + ]CNS establishes US operations
Consulting company Clinical Network Services (CNS) has established an office in the US to allow it to support clients seeking to engage with the FDA.
[ + ]Sirtex completes recruitment for SIR-Spheres trial
Sirtex Medical (ASX:SRX) has now recruited over 1000 patients for its three concurrent trials of its liver cancer treatment SIR-Spheres microspheres.
[ + ]AIMS council gets a revamp
The Australian Institute of Marine Science will start the year off with a new chair and three new members for its council. [ + ]
Minimally invasive treatment for lung disease in Australia
A minimally invasive procedure is now available to Australian patients suffering from obstructive lung diseases such as emphysema. An alternative to surgical resection of the most diseased part of a lung, endoscopic lung volume reduction (ELVR) involves having an umbrella-shaped, one-way valve endoscopically positioned into the airway serving the affected lobe. [ + ]
Rotaviruses need sugar receptors to invade cells
Rotaviruses invade cells of the gastrointestinal tract through carbohydrate receptors, findings that may lead to new ways of preventing this contagious childhood disease. [ + ]
Fellowship scheme for young dementia researchers
Minister for Education and Training Christopher Pyne has announced a new fellowship scheme to expand research capacity in dementia. The NHMRC-ARC Dementia Research Development Fellowships Scheme provides opportunities for postdoctoral researchers to engage in advanced training in the health, medical, fundamental sciences, social, economic and cultural fields relevant to dementia. [ + ]
Simulating the power of bubbles
Researchers have used the most powerful computer in Japan to explore a process observed in both bubbly beverages as well as scientific systems including spin systems, foams and metallic alloys. [ + ]
Science welcomed back to Australian Cabinet
The Australian Academy of Science has welcomed last month's announcement that Ian Macfarlane is now the Minister for Industry and Science - a move Academy President Professor Andrew Holmes hopes will be more than a change in title. [ + ]
